Identification
NameThymol
Accession NumberDB02513  (EXPT01913)
TypeSmall Molecule
GroupsApproved
Description

A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. (Dorland, 28th ed)

Structure
Thumb
Synonyms
2-isopropyl-5-methylphenol
5-Methyl-2-(1-Methylethyl)Phenol
IPMP
External IDs FEMA NO. 3066 / NSC-11215 / NSC-47821 / NSC-49142
Product Ingredients Not Available
Approved Prescription ProductsNot Available
Approved Generic Prescription ProductsNot Available
Approved Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Acne Vanish Synergy for Treatment Of AcnesOil.7 g/50gTopicalPhytopia Co., Ltd.2016-02-29Not applicableUs
Acute Bronchitis SynergyOil1.5 g/50gTopicalPhytopia Co., Ltd.2016-02-29Not applicableUs
Benefect Natural Hand SanitizerSpray.06 mL/120mLTopicalSensible Life Products2010-03-01Not applicableUs
Benefect Natural Hand SanitizerLiquid.5 mL/LTopicalSensible Life Products2010-03-01Not applicableUs
Chronic Bronchitis SynergyOil.5 g/50gTopicalPhytopia Co., Ltd.2016-02-29Not applicableUs
Cleanwell Natural Antibacterial Foaming LavenderSoap.0004 kg/kgTopicalClean Well2007-11-01Not applicableUs
Cleanwell Natural Antibacterial Foaming Orange VanillaSoap.0004 1/kgTopicalClean Well2007-11-01Not applicableUs
Cleanwell Natural Antibacterial Foaming Spearmint LimeSoap.0004 kg/kgTopicalClean Well2007-11-01Not applicableUs
Cleanwell Natural Orange Vanilla Hand SanitizerSpray.0005 kg/kgTopicalClean Well2007-11-01Not applicableUs
Cleanwell Natural Orange Vanilla Hand Sanitizing WipesCloth.0005 kg/kgTopicalClean Well2010-06-15Not applicableUs
Cleanwell Natural Original Hand Sanitizer WipesCloth.0005 kg/kgTopicalClean Well2010-06-15Not applicableUs
Common Colds SynergyOil1.5 g/50gTopicalPhytopia Co., Ltd.2016-02-29Not applicableUs
Ginger Bergamot Natural Antibacterial FoamingSoap.0004 kg/kgTopicalClean Well2007-11-01Not applicableUs
Influenza Care SynergyOil1.7 g/50gTopicalPhytopia Co., Ltd.2016-02-29Not applicableUs
Natures Antibac LavenderSoap.0024 kg/kgTopicalClean Well2012-02-01Not applicableUs
Natures Antibac Orange VanillaSoap.0024 kg/kgTopicalClean Well2012-02-01Not applicableUs
Natures Antibac PeppermintSoap.0024 kg/kgTopicalClean Well2012-02-01Not applicableUs
Unapproved/Other Products Not Available
International BrandsNot Available
Brand mixtures
NameLabellerIngredients
Advanced AntisepticWakfern Food Corporation
Advanced Antiseptic CitrusH.E.B.
Advanced CitrusWalmart Stores
Advanced Citrus AntisepticPublix Supermarkets, Inc.
Amber Mouth RinseFilo America
Amber Mouth Wash - LiqPerrigo International
Amber Mouthwash - LiqPerrigo International
Anitseptic Mouth RinsePharmacy Vlaue Alliance Llc
AntisepticTarget Corporation.
Antiseptic Lil Drug Store ProductsLil' Drug Store Products, Inc.
Antiseptic Mouth RinseWalgreens
Antiseptic Mouth Rinse - LiqPerrigo International
Antiseptic MouthrinseWalmart Stores
Antiseptic RinseMeijer
AntispeticWalgreen
Antispetic Mouth RinseOnpoint, Inc
Aurora Blue MintAPOLLO HEALTH AND BEAUTY CARE
Aurora Fresh BurstAPOLLO HEALTH AND BEAUTY CARE
Being Well AntisepticSave A Lot Food Stores, Ltd.
BiocenceBio Germ Protection Llc
BorasolLaboratorios Dr. Collado, C x A.
Buenos Dias De Personna Citrus FlavourInternational Cosmetic Limited
Buenos Dias De Personna Cool MintInternational Cosmetic Limited
Buenos Dias De Personna MintInternational Cosmetic Limited
Buenos Dias De Personna OriginalInternational Cosmetic Limited
CarboseptolHerbes Universelles Inc.
Cool Mint Antiseptic MouthwashScott Chemical Canada
Cresophene LiqSeptodont
Discount Drug Mart Blue Mint MouthwashDiscount Dollar Mart
Discount Drug Mart Original Flavor MouthwashDiscount Drug Mart
Discount Drug Mart Spring Mint MouthwashDiscount Drug Mart
Equate Tartar Control PlusWalmart Stores
Family Dollar Antiseptic Mouth RinseFamily Dollar
Family Dollar Antiseptic Mouth Rinse Blue MintFamily Dollar Services
Family Dollar Antiseptic Mouth Rinse Spring MintFamily Dollar
Forticept Antimicrobial GelCosco International, Inc.
Green Mint Mouth RinseFilo America
Handy Solutions Cool Mint Listerine Antiseptic MouthwashNavajo Manuracturing Company
Handy Solutions Listerine Antiseptic MouthwashNavajo Manuracturing Company
Hyvee Antiseptic Blue MintHyvee
Hyvee Antiseptic MintHyvee
Hyvee Antiseptic OriginalHyvee
Hyvee Blue MintHyvee
Hyvee Health Cool Blue Sugar FreeHyvee
Hyvee Health Green Mint Sugar FreeHyvee
LipsorexCanderm G.P.
Lipsorex - GelVexco Laboratories Inc.
Lipsorex PlusSanofi Consumer Health Inc Sanofi Sante Grand Public Inc
Lipsorex-gelVexco Laboratories Inc.
Listerine Advanced With Tartar Protection Antiseptic CitrusJohnson & Johnson Healthcare Products, Division Of Mc Neil Ppc, Inc.
Listerine AntisepticJohnson & Johnson Healthcare Products, Division Of Mc Neil Ppc, Inc.
Listerine Cool Mint AntisepticJohnson & Johnson
Listerine Freshburst AntisepticJohnson & Johnson
Listerine Naturals Antiseptic - Herbal MintJohnson & Johnson Healthcare Products, Division Of Mc Neil Ppc, Inc.
Listerine Ultraclean Antiseptic Arctic MintJohnson & Johnson Healthcare Products, Division Of Mc Neil Ppc, Inc.
Listerine Ultraclean Antiseptic Cool MintJohnson & Johnson Healthcare Products, Division Of Mc Neil Ppc, Inc.
Listerine Ultraclean Antiseptic Fresh CitrusJohnson & Johnson Healthcare Products, Division Of Mc Neil Ppc, Inc.
Marcs Blue MintAPOLLO HEALTH AND BEAUTY CARE
Marcs OriginalAPOLLO HEALTH AND BEAUTY CARE
Marcs Spring MintAPOLLO HEALTH AND BEAUTY CARE
Mastic DentChia Gi Ltd
Mouth RinseKroger
Nasal Jelly Thuna'sThuna Herbal Remedies Ltd.
Natur 911Bratch Laboratories
Oral Care AntisepticRite Aid
Oral Dent AmberInternational Cosmetic Limited
Oral Dent Blue MintInternational Cosmetic Limited
Oral Dent CitrusInternational Cosmetic Limited
Oral Dent Fresh MintInternational Cosmetic Limited
Oral-dent Blue MintInternational Cosmetic Limited
Original AntisepticPublix
Pastilles ValdaLabs Valda
Peppermint Mouth RinseFilo America
Quality Choice AmberChain Drug Marketing Association
Quality Choice Blue MintChain Drug Marketing Association
Quality Choice Sprng MintChain Drug Marketing Association
RinseWalgreen
Royal Mouthwash Fresh and Clean Original MintFilo America
Salonpas - Pls TopHisamitsu Pharmaceutical Co., Inc.
Salonpas Medicated PlasterHisamitsu Pharmaceutical Co., Inc.
Sinsinpap CoolSinsin Pharmaceutical Co., Ltd.
Smart Sense Blue MintKmart Corporation
Smart Sense CitrusKmart Corporation
Smart Sense Iceberg BlueKmart Corporation
Smart Sense Original FlavorKmart Corporation
Smart Sense Spring MintKmart Corporation
Soft Mint Listerine AntisepticJohnson & Johnson Healthcare Products, Division Of Mc Neil Ppc, Inc.
Tartar ControlWestern Family
Tartar Control PlusWalgreen
Valda PastillesBayer Inc Consumer Care
Valda Pastilles Lemon FlavouredLabs Valda
Vaporisateur MedicamenteAlsi Cie Ltee
Categories
UNII3J50XA376E
CAS number89-83-8
WeightAverage: 150.2176
Monoisotopic: 150.10446507
Chemical FormulaC10H14O
InChI KeyMGSRCZKZVOBKFT-UHFFFAOYSA-N
InChI
InChI=1S/C10H14O/c1-7(2)9-5-4-8(3)6-10(9)11/h4-7,11H,1-3H3
IUPAC Name
5-methyl-2-(propan-2-yl)phenol
SMILES
CC(C)C1=CC=C(C)C=C1O
Pharmacology
IndicationNot Available
Structured Indications
PharmacodynamicsNot Available
Mechanism of actionNot Available
Related Articles
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
MetabolismNot Available
Route of eliminationNot Available
Half lifeNot Available
ClearanceNot Available
ToxicityNot Available
Affected organismsNot Available
PathwaysNot Available
Pharmacogenomic Effects/ADRs Not Available
Interactions
Drug Interactions
DrugInteractionDrug group
AmlodipineThe risk or severity of adverse effects can be increased when Thymol is combined with Amlodipine.Approved
Amphotericin BThe therapeutic efficacy of Amphotericin B can be decreased when used in combination with Thymol.Approved, Investigational
AmrinoneThe risk or severity of adverse effects can be increased when Thymol is combined with Amrinone.Approved
AzelnidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Azelnidipine.Approved
AzimilideThe risk or severity of adverse effects can be increased when Thymol is combined with Azimilide.Investigational
BarnidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Barnidipine.Approved
BenidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Benidipine.Approved
BepridilThe risk or severity of adverse effects can be increased when Thymol is combined with Bepridil.Approved, Withdrawn
BuspironeThe metabolism of Buspirone can be decreased when combined with Thymol.Approved, Investigational
BusulfanThe serum concentration of Busulfan can be increased when it is combined with Thymol.Approved, Investigational
CarboxyamidotriazoleThe risk or severity of adverse effects can be increased when Thymol is combined with Cai.Investigational
CilnidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Cilnidipine.Approved
CinnarizineThe risk or severity of adverse effects can be increased when Thymol is combined with Cinnarizine.Approved
CisaprideThe serum concentration of Cisapride can be increased when it is combined with Thymol.Approved, Investigational, Withdrawn
ClevidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Clevidipine.Approved
ConivaptanThe metabolism of Conivaptan can be decreased when combined with Thymol.Approved, Investigational
CyclosporineThe metabolism of Cyclosporine can be decreased when combined with Thymol.Approved, Investigational, Vet Approved
DarodipineThe risk or severity of adverse effects can be increased when Thymol is combined with Darodipine.Experimental
DidanosineDidanosine can cause a decrease in the absorption of Thymol resulting in a reduced serum concentration and potentially a decrease in efficacy.Approved
DiltiazemThe risk or severity of adverse effects can be increased when Thymol is combined with Diltiazem.Approved
DocetaxelThe metabolism of Docetaxel can be decreased when combined with Thymol.Approved, Investigational
DofetilideThe metabolism of Dofetilide can be decreased when combined with Thymol.Approved
EfonidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Efonidipine.Approved
EperisoneThe risk or severity of adverse effects can be increased when Thymol is combined with Eperisone.Approved, Investigational
EtravirineThe serum concentration of Etravirine can be increased when it is combined with Thymol.Approved
FelodipineThe risk or severity of adverse effects can be increased when Thymol is combined with Felodipine.Approved, Investigational
FendilineThe risk or severity of adverse effects can be increased when Thymol is combined with Fendiline.Withdrawn
FlunarizineThe risk or severity of adverse effects can be increased when Thymol is combined with Flunarizine.Approved
FosphenytoinThe serum concentration of Thymol can be decreased when it is combined with Fosphenytoin.Approved
GabapentinThe risk or severity of adverse effects can be increased when Thymol is combined with Gabapentin.Approved, Investigational
GallopamilThe risk or severity of adverse effects can be increased when Thymol is combined with Gallopamil.Investigational
IsradipineThe risk or severity of adverse effects can be increased when Thymol is combined with Isradipine.Approved
LacidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Lacidipine.Approved
LamotrigineThe risk or severity of adverse effects can be increased when Thymol is combined with Lamotrigine.Approved, Investigational
LercanidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Lercanidipine.Approved, Investigational
LosartanThe metabolism of Losartan can be decreased when combined with Thymol.Approved
Magnesium SulfateThe risk or severity of adverse effects can be increased when Thymol is combined with Magnesium Sulfate.Approved, Vet Approved
ManidipineThe risk or severity of adverse effects can be increased when Thymol is combined with Manidipine.Approved
MibefradilThe risk or severity of adverse effects can be increased when Thymol is combined with Mibefradil.Withdrawn
NaftopidilThe risk or severity of adverse effects can be increased when Thymol is combined with Naftopidil.Investigational
NicardipineThe risk or severity of adverse effects can be increased when Thymol is combined with Nicardipine.Approved
NifedipineThe risk or severity of adverse effects can be increased when Thymol is combined with Nifedipine.Approved
NiguldipineThe risk or severity of adverse effects can be increased when Thymol is combined with Niguldipine.Experimental
NiludipineThe risk or severity of adverse effects can be increased when Thymol is combined with Niludipine.Experimental
NilvadipineThe risk or severity of adverse effects can be increased when Thymol is combined with Nilvadipine.Approved
NimesulideThe risk or severity of adverse effects can be increased when Thymol is combined with Nimesulide.Approved, Withdrawn
NimodipineThe risk or severity of adverse effects can be increased when Thymol is combined with Nimodipine.Approved
NisoldipineThe risk or severity of adverse effects can be increased when Thymol is combined with Nisoldipine.Approved
NitrendipineThe risk or severity of adverse effects can be increased when Thymol is combined with Nitrendipine.Approved
PerhexilineThe risk or severity of adverse effects can be increased when Thymol is combined with Perhexiline.Approved
PhenytoinThe serum concentration of Phenytoin can be increased when it is combined with Thymol.Approved, Vet Approved
PimozideThymol may increase the arrhythmogenic activities of Pimozide.Approved
PinaveriumThe risk or severity of adverse effects can be increased when Thymol is combined with Pinaverium.Approved
PregabalinThe risk or severity of adverse effects can be increased when Thymol is combined with Pregabalin.Approved, Illicit, Investigational
PrenylamineThe risk or severity of adverse effects can be increased when Thymol is combined with Prenylamine.Withdrawn
ProgesteroneThe therapeutic efficacy of Progesterone can be decreased when used in combination with Thymol.Approved, Vet Approved
QuinidineThe metabolism of Quinidine can be decreased when combined with Thymol.Approved
RanolazineThe metabolism of Ranolazine can be decreased when combined with Thymol.Approved, Investigational
RifabutinThe serum concentration of Rifabutin can be increased when it is combined with Thymol.Approved
RifampicinThe serum concentration of Rifampicin can be increased when it is combined with Thymol.Approved
RifapentineThe serum concentration of Rifapentine can be increased when it is combined with Thymol.Approved
RisedronateThe risk or severity of adverse effects can be increased when Thymol is combined with Risedronate.Approved, Investigational
SolifenacinThe metabolism of Solifenacin can be decreased when combined with Thymol.Approved
SucralfateSucralfate can cause a decrease in the absorption of Thymol resulting in a reduced serum concentration and potentially a decrease in efficacy.Approved
SunitinibThe metabolism of Sunitinib can be decreased when combined with Thymol.Approved, Investigational
TacrolimusThe metabolism of Tacrolimus can be decreased when combined with Thymol.Approved, Investigational
Tolfenamic AcidThe risk or severity of adverse effects can be increased when Thymol is combined with Tolfenamic Acid.Approved
TranilastThe risk or severity of adverse effects can be increased when Thymol is combined with Tranilast.Approved, Investigational
VerapamilThe risk or severity of adverse effects can be increased when Thymol is combined with Verapamil.Approved
VinpocetineThe risk or severity of adverse effects can be increased when Thymol is combined with Vinpocetine.Investigational
XylometazolineThe risk or severity of adverse effects can be increased when Thymol is combined with Xylometazoline.Approved
ZiconotideThe risk or severity of adverse effects can be increased when Thymol is combined with Ziconotide.Approved
ZolpidemThe serum concentration of Zolpidem can be increased when it is combined with Thymol.Approved
Food InteractionsNot Available
References
Synthesis ReferenceNot Available
General ReferencesNot Available
External Links
ATC CodesNot Available
AHFS CodesNot Available
PDB Entries
FDA labelNot Available
MSDSNot Available
Clinical Trials
Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedPreventionNeonatal Infections1
4CompletedTreatmentAggressive Periodontitis1
Not AvailableRecruitingTreatmentPeriodontitis / Type 2 Diabetes Mellitus1
Pharmacoeconomics
ManufacturersNot Available
PackagersNot Available
Dosage forms
FormRouteStrength
OilTopical.7 g/50g
OilTopical1.5 g/50g
LiquidDental
RinseOral
MouthwashOral
MouthwashBuccal
LiquidTopical.5 mL/L
SprayTopical.06 mL/120mL
LotionTopical
SprayTopical
PowderTopical
OintmentTopical
OilTopical.5 g/50g
SoapTopical.0004 1/kg
SprayTopical.0005 kg/kg
ClothTopical.0005 kg/kg
MouthwashBuccal; Oral
SoapTopical.0004 kg/kg
LiquidOral
OilTopical1.7 g/50g
GelTopical
MouthwashDental; Oral
JellyNasal
LiquidTopical
SoapTopical.0024 kg/kg
LozengeOral
PlasterTopical
PatchCutaneous; Topical; Transdermal
MouthwashDental
LiquidRespiratory (inhalation)
PricesNot Available
PatentsNot Available
Properties
StateSolid
Experimental Properties
PropertyValueSource
melting point (°C)51.5 °CPhysProp
boiling point (°C)232.5 °CPhysProp
water solubility900 mg/L (at 20 °C)YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP3.30HANSCH,C ET AL. (1995)
pKa10.6 (at 20 °C)SERJEANT,EP & DEMPSEY,B (1979)
Predicted Properties
PropertyValueSource
Water Solubility0.643 mg/mLALOGPS
logP3.16ALOGPS
logP3.43ChemAxon
logS-2.4ALOGPS
pKa (Strongest Acidic)10.59ChemAxon
pKa (Strongest Basic)-5.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area20.23 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity47.27 m3·mol-1ChemAxon
Polarizability17.84 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9955
Blood Brain Barrier+0.9381
Caco-2 permeable+0.9153
P-glycoprotein substrateNon-substrate0.722
P-glycoprotein inhibitor INon-inhibitor0.9343
P-glycoprotein inhibitor IINon-inhibitor0.9883
Renal organic cation transporterNon-inhibitor0.9036
CYP450 2C9 substrateNon-substrate0.7352
CYP450 2D6 substrateSubstrate0.7838
CYP450 3A4 substrateNon-substrate0.5667
CYP450 1A2 substrateInhibitor0.9107
CYP450 2C9 inhibitorNon-inhibitor0.907
CYP450 2D6 inhibitorNon-inhibitor0.9368
CYP450 2C19 inhibitorNon-inhibitor0.9026
CYP450 3A4 inhibitorNon-inhibitor0.9196
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7429
Ames testNon AMES toxic0.9282
CarcinogenicityNon-carcinogens0.7195
BiodegradationNot ready biodegradable0.7808
Rat acute toxicity2.2996 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8987
hERG inhibition (predictor II)Non-inhibitor0.9087
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397 )
Spectra
Mass Spec (NIST)Not Available
Spectra
Spectrum TypeDescriptionSplash Key
Predicted GC-MSPredicted GC-MS Spectrum - GC-MSNot Available
GC-MSGC-MS Spectrum - EI-Bsplash10-000i-0900000000-333dc57384e65e3b4cfaView in MoNA
GC-MSGC-MS Spectrum - EI-Bsplash10-000i-1900000000-3679938a5ea114a30e48View in MoNA
GC-MSGC-MS Spectrum - EI-Bsplash10-000i-3900000000-8ce5865e48dad7250d5eView in MoNA
GC-MSGC-MS Spectrum - EI-Bsplash10-0udi-0109030000-5562c203cb318f30321bView in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)splash10-01p9-9700000000-e1a28495617d7b014e5cView in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)splash10-014i-9300000000-baeee6cdcafaadeebdecView in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)splash10-015c-9100000000-e1efa41eaf818832448aView in MoNA
LC-MS/MSLC-MS/MS Spectrum - EI-B (SHIMADZU LKB-9000B) , Positivesplash10-000i-0900000000-333dc57384e65e3b4cfaView in MoNA
LC-MS/MSLC-MS/MS Spectrum - EI-B (HITACHI RMU-6L) , Positivesplash10-000i-1900000000-3679938a5ea114a30e48View in MoNA
LC-MS/MSLC-MS/MS Spectrum - EI-B (HITACHI M-80B) , Positivesplash10-000i-3900000000-f72f603d97f0f7081b8dView in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, NegativeNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, NegativeNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, NegativeNot Available
MSMass Spectrum (Electron Ionization)splash10-000i-4900000000-73edaa628c1f5f2e1bd9View in MoNA
1D NMR1H NMR SpectrumNot Available
1D NMR13C NMR SpectrumNot Available
2D NMR[1H,13C] 2D NMR SpectrumNot Available
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as aromatic monoterpenoids. These are monoterpenoids containing at least one aromatic ring.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassPrenol lipids
Sub ClassMonoterpenoids
Direct ParentAromatic monoterpenoids
Alternative ParentsMonocyclic monoterpenoids / Phenylpropanes / Cumenes / Meta cresols / Toluenes / 1-hydroxy-4-unsubstituted benzenoids / 1-hydroxy-2-unsubstituted benzenoids / Organooxygen compounds / Hydrocarbon derivatives
SubstituentsP-cymene / Aromatic monoterpenoid / Monocyclic monoterpenoid / Cumene / Phenylpropane / M-cresol / 1-hydroxy-4-unsubstituted benzenoid / 1-hydroxy-2-unsubstituted benzenoid / Phenol / Toluene
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptorsphenols, monoterpenoid (CHEBI:27607 ) / Menthane monoterpenoids, Cyclic monoterpenes (C09908 ) / Menthane monoterpenoids (LMPR0102090029 )
Drug created on June 13, 2005 07:24 / Updated on June 24, 2017 13:20